Provided by Tiger Fintech (Singapore) Pte. Ltd.

Aerovate Therapeutics, Inc.

9.80
+0.0000
Volume:- -
Turnover:- -
Market Cap:284.05M
PE:-5.76
High:9.80
Open:9.80
Low:9.80
Close:9.80
Loading ...
Apr 30, 2025

Major Issues Report

Form 8-K - Current report
Apr 25, 2025

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Apr 23, 2025

Major Issues Report

Form 8-K - Current report
Apr 21, 2025

Major Issues Report

Form 8-K - Current report
Apr 09, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Apr 09, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Apr 09, 2025

Major Issues Report

Form 8-K - Current report
Apr 09, 2025

Major Issues Report

Form 8-K - Current report
Apr 09, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Apr 07, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Apr 07, 2025

Major Issues Report

Form 8-K - Current report
Apr 07, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Mar 27, 2025

Annual Report

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Mar 26, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Mar 04, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Feb 10, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Feb 04, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jan 24, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Jan 13, 2025

Business Combinations

Form 425 - Prospectuses and communications, business combinations
Nov 18, 2024

Business Combinations

Form 425 - Prospectuses and communications, business combinations